SEB Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.4M Hold
42,705
– – 0.05% 289
2026
Q2
$14.3M Buy
+42,705
New +$13.5M 0.05% 283

Other funds holding PRAX

SEB Asset Management's PRAX Position: Q3 2026 in Review

SEB Asset Management held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 42,705 shares worth $12.4M. The position accounts for 0.05% of the portfolio, ranked #289.

SEB Asset Management first reported a position in PRAX in Q2 2026 and has held it in 2 quarters since. The position peaked at $14.3M in Q2 2026. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • SEB Asset Management held 42,705 shares of Praxis Precision Medicines worth $12.4M as of Q3 2026.
  • SEB Asset Management left its Praxis Precision Medicines share count unchanged in Q3 2026.
  • Praxis Precision Medicines made up 0.05% of SEB Asset Management's portfolio in Q3 2026, its #289 holding.
  • SEB Asset Management first reported a position in Praxis Precision Medicines in Q2 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Praxis Precision Medicines position peaked at $14.3M in Q2 2026.
  • 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.